The serum levels of Receptor Activator of Nuclear Factor-κB Ligand, bone-specific alkaline phosphatase, osteocalcin and osteoprotegerin do not correlate with the radiographically assessed severity of idiopathic hip and knee osteoarthritis

被引:5
作者
Kenanidis, Eustathios I. [1 ]
Potoupnis, Michael E. [1 ]
Papavasiliou, Kyriakos A. [1 ]
Pellios, Stauros [1 ]
Sayegh, Fares E. [1 ]
Petsatodis, George E. [1 ]
Karatzas, Nikolaos [1 ]
Kapetanos, George A. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Med, Papageorgiou Gen Hosp, Orthopaed Dept 3, GR-54006 Thessaloniki, Greece
关键词
Bone turnover markers; Receptor Activator of Nuclear Factor-kappa B Ligand; Bone-specific alkaline phosphatase; Osteocalcin; Osteoprotegerin; Hip osteoarthritis; Knee osteoarthritis; SYNOVIAL-FLUID; DISEASE SEVERITY; II COLLAGEN; OPG; BIOMARKERS; MARKERS; SYSTEM; RANKL; CELLS; RATIO;
D O I
10.1016/j.clinbiochem.2010.09.029
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Determination of the serum levels of Receptor Activator of Nuclear Factor-Kb Ligand, bone-specific alkaline phosphatase, osteocalcin and osteoprotegerin in patients suffering from osteoarthritis of varying severity and healthy controls and correlation of these results with the patients' age and the radiographically assessed severity of the disease. Design and methods: Patients suffering from hip (n=58) or knee (n=117) osteoarthritis and matched controls (n=19) were enrolled in this study. Patients underwent physical examination and standard radiographic evaluation before blood sampling. Results: The serum levels of osteoprotegerin were positively correlated with age in all groups, whereas those of osteocalcin in the 'knee' group only. Osteoarthritis' severity and location did not have a statistically significant impact on the mean serum level of any marker in both groups. Conclusions: Based on our results, none of the studied markers can serve as a surrogate for radiographic imaging in patients suffering from hip and knee osteoarthritis. (C) 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:203 / 207
页数:5
相关论文
共 31 条
  • [1] Bailey AJ, 2009, AGE AGEING, V30, P374
  • [2] JOINT SPACE WIDTH MEASURES CARTILAGE THICKNESS IN OSTEOARTHRITIS OF THE KNEE - HIGH-RESOLUTION PLAIN FILM AND DOUBLE-CONTRAST MACRORADIOGRAPHIC INVESTIGATION
    BUCKLANDWRIGHT, JC
    MACFARLANE, DG
    LYNCH, JA
    JASANI, MK
    BRADSHAW, CR
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (04) : 263 - 268
  • [3] Can biochemical markers serve as surrogates for imaging in knee osteoarthritis?
    Davis, C. R.
    Karl, J.
    Granell, R.
    Kirwan, J. R.
    Fasham, J.
    Johansen, J.
    Garnero, P.
    Sharif, M.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4038 - 4047
  • [4] Biomarkers in osteoarthritis
    Garnero, P
    Delmas, PD
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (05) : 641 - 646
  • [5] Use of biochemical markers to study and follow patients with osteoarthritis
    Garnero P.
    [J]. Current Rheumatology Reports, 2006, 8 (1) : 37 - 44
  • [6] Receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis
    Grimaud, E
    Soubigou, L
    Couillaud, S
    Coipeau, P
    Moreau, A
    Passuti, N
    Gouin, F
    Redini, F
    Heymann, D
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05) : 2021 - 2031
  • [7] Type II collagen markers in osteoarthritis: what do they indicate?
    Henrotin, Yves
    Addison, Shelby
    Kraus, Virginia
    Deberg, Michelle
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (05) : 444 - 450
  • [8] Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO
  • [9] 2-X
  • [10] Serum measurement of osteoprotegerin - clinical relevance and potential applications
    Hofbauer, LC
    Schoppet, M
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (06) : 681 - 683